Načítá se...
Applications of CRISPR/Cas9 for the Treatment of Duchenne Muscular Dystrophy
Duchenne muscular dystrophy (DMD) is a fatal X-linked recessive neuromuscular disease prevalent in 1 in 3500 to 5000 males worldwide. As a result of mutations that interrupt the reading frame of the dystrophin gene (DMD), DMD is characterized by a loss of dystrophin protein that leads to decreased m...
Uloženo v:
| Vydáno v: | J Pers Med |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
MDPI
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6313657/ https://ncbi.nlm.nih.gov/pubmed/30477208 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jpm8040038 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|